{"entity":{"type":"insider","cik":"0001686157","url":"/insider/0001686157","json_url":"/insider/0001686157.json","name":"Fairmount Healthcare Fund L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2021-09-23","last":"2024-01-24","span_basis":"filed_date"},"name_variants":[{"name":"Fairmount Healthcare Fund L.P.","source":"filing","n_filings":4,"first_seen":"2021-09-23","last_seen":"2024-01-24"}],"transactions":[{"id":2080400,"accession":"0000950170-24-007123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-007123","line_url":"/filing/0000950170-24-007123#line-1","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":null,"owner_name":"Fairmount Funds Management LLC; Fairmount Healthcare Fund GP LLC; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Fund L.P.","owner_display_name":"Fairmount Funds Management LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":476190.0,"shares_display":"476,190","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":1839954.0,"shares_owned_after_display":"1,839,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-24","scope":"insider"},{"id":7844257,"accession":"0001104659-23-081729","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-081729","line_url":"/filing/0001104659-23-081729","is_derivative":false,"issuer_cik":"0001663607","issuer_name":"Apogee Therapeutics, Inc.","issuer_ticker":"APGE","issuer_name_source":null,"issuer_url":"/issuer/0001663607","owner_cik":null,"owner_name":"Fairmount Healthcare Fund L.P.; Harwin Peter Evan; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Co-Invest II L.P.; Fairmount Funds Management LLC; Kiselak Tomas","owner_display_name":"Fairmount Healthcare Fund L.P.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2941176.0,"shares_display":"2,941,176","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":49999992.0,"total_display":"49,999,992.00","total_whole":"49,999,992","shares_owned_after":1992734.0,"shares_owned_after_display":"1,992,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-17","scope":"insider","n_lines":3},{"id":6718455,"accession":"0001104659-22-092992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-092992","line_url":"/filing/0001104659-22-092992#line-1","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":null,"owner_name":"Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Fund L.P.; Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund GP LLC; Fairmount Funds Management LLC","owner_display_name":"Fairmount Healthcare Fund II L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":425531.0,"shares_display":"425,531","price_per_share":23.5,"price_display":"23.50","price_state":"stated","total_value":9999978.5,"total_display":"9,999,978.50","total_whole":"9,999,979","shares_owned_after":1363764.0,"shares_owned_after_display":"1,363,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":4123299,"accession":"0000899243-21-037255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-037255","line_url":"/filing/0000899243-21-037255#line-1","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":null,"owner_name":"Fairmount Healthcare Fund II GP LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Fund L.P.; Fairmount Funds Management LLC; Fairmount Healthcare Fund GP LLC","owner_display_name":"Fairmount Healthcare Fund II GP LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":909000.0,"shares_display":"909,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":9999000.0,"total_display":"9,999,000.00","total_whole":"9,999,000","shares_owned_after":938233.0,"shares_owned_after_display":"938,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001590750","name":"Viridian Therapeutics, Inc.\\DE","url":"/issuer/0001590750","role":"Director, Ten percent owner, Other","n_filings":3,"first_seen":"2021-09-23","last_seen":"2024-01-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001974640","name":"Apogee Therapeutics, Inc.","url":"/issuer/0001974640","role":"Director","n_filings":1,"first_seen":"2023-07-17","last_seen":"2023-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001686157","retrieved_at":"2026-08-26T03:27:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}